Greminger P, Eichhorn P, Hess O M, Vetter W, Krayenbühl H P
Schweiz Med Wochenschr. 1985 Nov 9;115(45):1612-5.
In the present study 13 patients with severe chronic heart failure were investigated by right heart catheterization at rest and during handgrip before and 6 months after treatment with captopril (mean dose 2 X 37.5 mg per day). Before initiating captopril therapy all patients were clinically stable on digitalis and diuretics. During the observation period 3 patients died suddenly. Of the remaining cases, 5 had dilated cardiomyopathy and 5 ischemic heart disease. After 6 months, resting hemodynamic measurements changed as follows: systemic vascular resistance decreased from 1594 to 1284 dyn X sec X cm-5 (p less than 0.005), left ventricular end-diastolic pressure decreased from 17 to 10 mm Hg (p less than 0.01) and stroke volume index increased from 32 to 40 ml/m2 (p less than 0.05). Before captopril, 9 patients showed no increase or even a decrease of stroke work index during isometric exercise, whereas after captopril 5 out of the 10 patients showed an increase in stroke work index. The results demonstrate that, in patients with severe chronic heart failure, long-term afterload reduction with captopril is accompanied by a significant improvement in left ventricular performance at rest. Furthermore, during isometric exercise after captopril an improvement in left ventricular function was found in 5 out of 10 patients.
在本研究中,对13例重度慢性心力衰竭患者在静息状态下、握力试验期间以及使用卡托普利(平均剂量为每日2×37.5毫克)治疗前和治疗6个月后进行了右心导管检查。在开始卡托普利治疗前,所有患者在使用洋地黄和利尿剂的情况下临床症状稳定。在观察期内,有3例患者突然死亡。其余病例中,5例患有扩张型心肌病,5例患有缺血性心脏病。6个月后,静息血流动力学测量结果变化如下:全身血管阻力从1594降至1284达因×秒×厘米⁻⁵(p<0.005),左心室舒张末期压力从17毫米汞柱降至10毫米汞柱(p<0.01),每平方米体表面积的搏出量指数从32毫升增加至40毫升(p<0.05)。在使用卡托普利前,9例患者在等长运动期间搏功指数未增加甚至降低,而在使用卡托普利后,10例患者中有5例搏功指数增加。结果表明,在重度慢性心力衰竭患者中,长期使用卡托普利降低后负荷可使静息状态下左心室功能显著改善。此外,在使用卡托普利后的等长运动期间,10例患者中有5例左心室功能得到改善。